JPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL IND

An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.

560900 trades at 0.843 CNY today, its price has fallen −1.75% in the past 24 hours. Track more dynamics on 560900 price chart.

Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.

560900 invests in stocks. See more details in our Analysis section.

560900 expense ratio is 0.40%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.

In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 560900 technical analysis shows the neutral rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 560900 shows the buy signal. See more of 560900 technicals for a more comprehensive analysis.

No, 560900 doesn't pay dividends to its holders.

560900 shares are issued by JPMorgan Chase & Co.

560900 follows the CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

The fund started trading on May 9, 2022.